The Chinese DNA sequencing market is expanding rapidly due to rising demand for precision medicine, technological advancements, and government investments. Key opportunities lie in oncology ...
GeneDx announces that the FDA has granted Breakthrough Device Designation for its whole genome and exome tests.
TipRanks on MSN
GRAIL Inc Secures $325 Million in Private Placement
The latest update is out from GRAIL Inc ( (GRAL) ).
Recent headlines proclaim a ‘potential’ or ‘functional’ cure for multiple myeloma, but the fight against the disease must ...
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...
Therefore, based on their findings, they recommend a comprehensive eye exam for patients living with MG who experience vision ...
US-based company is developing next-generation sequencers, using AI models in the Republic to speed up diagnostics and lower ...
Zacks Investment Research on MSN
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced innovations to its Revio and Vega platforms last week. The innovations are expected to lower sequencing costs, add ...
Viridian Therapeutics, Inc. , a biotechnology company focused on discovering, developing and commercializing potentially best-in-class medicines for serious and rare diseases, today announced it ...
GRAIL believes its cash, cash equivalents and investments, including the expected net proceeds from the private placement, will provide sufficient funding of planned operations into 2030, not ...
Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicines, today announced the presentation of two-year data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results